lutein/sarcoma

OBJECTIVE Multidrug resistance and toxicity significantly compromise the therapeutic efficacy for sarcomas. We aimed at evaluating the effect of lutein-doxorubicin (DOX) combinatorial therapy on inhibiting S180 (Sarcoma 180) cell proliferation and tumor growth. METHODS S180 cells in logarithmic

Inhibin is a glycoprotein hormone produced by normal ovarian granulosa cells and testicular sertoli cells. In the ovary, it inhibits the secretion of follicle-stimulating hormone. Patients with granulosa cell tumors (GCT) have elevated serum levels of inhibin and this finding has been used to detect

The progesterone level in the peripheral blood and morphometrical analysis of the endometrial functional layer were carried out in 8 cases of surgically removed intramural uterine sarcoma. A statistically significant high correlation between the two indexes allow recommending morphometrical methods